Literature DB >> 10609619

Health-care costs of inner-city patients with asthma.

K T Stroupe1, D Gaskins, M D Murray.   

Abstract

We estimated the health-care costs accrued by inner-city asthma patients over 1 year and identified patient characteristics associated with high cost patterns. The direct cost to the health-care provider of 1205 patients with an active diagnosis of asthma was $2.5 million, of which $888,000 (35.5%) was for asthma management. The average cost of an outpatient visit was $188, but was $3812 for a hospital admission. Outpatient visits for asthma comprised the largest volume of usage (96.2%) and the largest cost (55.4%). Although 104 hospital admissions of 84 patients (7%) comprised only 3.8% of the total encounters for asthma, they comprised 44.6% of asthma costs. Strategies emphasizing preventive care resulting in 20% greater outpatient costs would pay for themselves if they reduced inpatient admissions by 10%.

Entities:  

Mesh:

Year:  1999        PMID: 10609619     DOI: 10.3109/02770909909055416

Source DB:  PubMed          Journal:  J Asthma        ISSN: 0277-0903            Impact factor:   2.515


  10 in total

1.  Issues in conducting randomized controlled trials of health services research interventions in nonacademic practice settings: the case of retail pharmacies.

Authors:  Morris Weinberger; Michael D Murray; David G Marrero; Nancy Brewer; Michael Lykens; Lisa E Harris; A Jeffrey Newell; Joyce Collins; William M Tierney
Journal:  Health Serv Res       Date:  2002-08       Impact factor: 3.402

2.  The Seattle-King County Healthy Homes Project: a randomized, controlled trial of a community health worker intervention to decrease exposure to indoor asthma triggers.

Authors:  James W Krieger; Tim K Takaro; Lin Song; Marcia Weaver
Journal:  Am J Public Health       Date:  2005-04       Impact factor: 9.308

3.  Direct health care costs associated with asthma in British Columbia.

Authors:  Mohsen Sadatsafavi; Larry Lynd; Carlo Marra; Bruce Carleton; Wan C Tan; Sean Sullivan; J Mark Fitzgerald
Journal:  Can Respir J       Date:  2010 Mar-Apr       Impact factor: 2.409

4.  Access and Utilization of Asthma Medications Among Patients Who Receive Care in Federally Qualified Health Centers.

Authors:  Asma M Ali; Anne H Gaglioti; Rebecca H Stone; Natalie D Crawford; Kevin K Dobbin; Lokesh Guglani; Henry N Young
Journal:  J Prim Care Community Health       Date:  2022 Jan-Dec

5.  Patient And phaRmacist Telephonic Encounters (PARTE) in an underserved rural population with asthma: methods and rationale.

Authors:  Henry N Young; S Nadra Havican; Betty A Chewning; Christine A Sorkness; Xin Ruppel; Sara Griesbach
Journal:  Innov Pharm       Date:  2011-07-01

6.  Demographic disparities in patient-reported use of inhaled corticosteroids among patients with persistent asthma.

Authors:  Varun Vaidya; Monica Holiday-Goodman; Sharrel Pinto
Journal:  J Asthma Allergy       Date:  2010-08-24

7.  Economic burden of asthma among patients visiting a private hospital in South India.

Authors:  Surendran Aneeshkumar; Raj B Singh
Journal:  Lung India       Date:  2018 Jul-Aug

Review 8.  Economic burden of asthma: a systematic review.

Authors:  Katayoun Bahadori; Mary M Doyle-Waters; Carlo Marra; Larry Lynd; Kadria Alasaly; John Swiston; J Mark FitzGerald
Journal:  BMC Pulm Med       Date:  2009-05-19       Impact factor: 3.317

Review 9.  Childhood asthma and environmental interventions.

Authors:  Felicia Wu; Tim K Takaro
Journal:  Environ Health Perspect       Date:  2007-01-25       Impact factor: 9.031

10.  Effects of oral montelukast on airway function in acute asthma: A randomized trial.

Authors:  Alisha Chaudhury; Gajanan S Gaude; Jyothi Hattiholi
Journal:  Lung India       Date:  2017 Jul-Aug
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.